Is ADDXF or JEPI a better dividend investment in 2026?

ADDXF currently yields 202.02% with a 5% 5-year dividend growth rate. JEPI yields 8.40% with 2.1% growth. The better choice depends on your goal: ADDXF offers higher current income.

What is the dividend yield difference between ADDXF and JEPI?

ADDXF has a forward dividend yield of 202.02% ($2.00/share annually). JEPI yields 8.40% ($4.76/share annually). The yield gap is 193.62 percentage points.

Home › Compare › ADDXF vs JEPI

ADDXF vs JEPI: Dividend Comparison 2026

ADDXF yields 202.02% · JEPI yields 8.40%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADDXF wins by $126.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADDXF

● Live price

202.02%

Share price

$0.99

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$126.53M

Annual income

$64,106,411.82

Full ADDXF calculator →

JEPI

JPMorgan Equity Premium Income ETF

● Live price

8.40%

Share price

$56.68

Annual div

$4.76

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$1,528.62

Full JEPI calculator →

Portfolio growth — ADDXF vs JEPI

📍 ADDXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADDXF	JEPI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADDXF + JEPI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADDXF pays

JEPI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADDXF

Annual income on $10K today (after 15% tax)

$17,171.72/yr

After 10yr DRIP, annual income (after tax)

$54,490,450.05/yr

JEPI

Annual income on $10K today (after 15% tax)

$714.16/yr

After 10yr DRIP, annual income (after tax)

$1,299.33/yr

At 15% tax rate, ADDXF beats the other by $54,489,150.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADDXF + JEPI for your $10,000?

ADDXF: 50%JEPI: 50%

100% JEPI50/50100% ADDXF

Portfolio after 10yr

$63.28M

Annual income

$32,053,970.22/yr

Blended yield

50.65%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADDXF buys

JEPI buys

No recent congressional trades found for ADDXF or JEPI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADDXFJEPI

Forward yield	202.02% ✓	8.40%
Annual dividend / share	$2.00	$4.76 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$126.53M ✓	$29.0K
Annual income after 10y	$64,106,411.82 ✓	$1,528.62
Total dividends collected	$119.31M ✓	$11.7K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ADDXF vs JEPI ($10,000, DRIP)

Year	ADDXF Portfolio	ADDXF Income/yr	JEPI Portfolio	JEPI Income/yr	Gap
1← crossover	$30,902	$20,202.02	$11,260	$840.19	+$19.6K → ADDXF
2	$91,409	$58,344.23	$12,641	$907.94	+$78.8K → ADDXF
3	$259,102	$161,293.94	$14,150	$978.20	+$245.0K → ADDXF
4	$704,521	$427,281.62	$15,795	$1,050.85	+$688.7K → ADDXF
5	$1,839,646	$1,085,809.10	$17,584	$1,125.74	+$1.82M → ADDXF
6	$4,618,204	$2,649,782.60	$19,526	$1,202.74	+$4.60M → ADDXF
7	$11,158,255	$6,216,776.60	$21,628	$1,281.69	+$11.14M → ADDXF
8	$25,977,314	$14,037,980.69	$23,898	$1,362.43	+$25.95M → ADDXF
9	$58,339,227	$30,543,501.04	$26,347	$1,444.79	+$58.31M → ADDXF
10	$126,529,384	$64,106,411.82	$28,982	$1,528.62	+$126.50M → ADDXF

ADDXF vs JEPI: Complete Analysis 2026

ADDXF — Stock

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Full ADDXF Calculator →

JEPI — ETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →

📬

Get this ADDXF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADDXF vs SCHD ADDXF vs O ADDXF vs KO ADDXF vs MAIN ADDXF vs JEPQ ADDXF vs XYLD ADDXF vs DIVO ADDXF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.